相关实验视频

Updated: Jan 17, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

针对Mycobacterium Tuberculosis的先进治疗干预措施

A A Razzak Mahmood¹, V I Rani², P Yadav³

¹Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad. Bab Al-Mouadam, 10001. Baghdad, Iraq.

Archives of Razi Institute

|September 15, 2025

概括

结核病感染 (TBI) 仍然是一个全球性威胁,特别影响弱势群体. 诊断,预防疗法和人工智能集成方面的进展为改善TBI治疗和患者护理提供了有希望的策略.

科学领域:

传染性疾病传染性疾病
公共卫生公共卫生
医学研究医学研究

背景情况:

由Mycobacterium tuberculosis引起的结核病感染 (TBI) 是一个持续的全球健康威胁.
艾滋病毒/艾滋病,弱势群体和社会经济因素加剧了TBI患病率.
随着COVID-19的流行,TBI的诊断和治疗受到干扰,影响了患者的治疗结果.

研究的目的:

审查影响TBI患病率的弱势群体,高风险群体和社会经济因素.
为了探索TBI和COVID-19大流行病的交叉点.
讨论TBI诊断,治疗和人工智能 (AI) 整合方面的进展.

主要方法:

文献综述检查TBI患病率,风险因素和全球影响.
对诊断进步的分析,包括像干扰素玛释放试验 (IGRAs) 这样的生物标志物.
对药物耐药菌株的预防疗法 (例如,异化预防疗法) 和组合治疗的评估.
探索AI在优化TBI治疗和个性化患者护理方面的作用.

主要成果:

对TBI的脆弱性受到年龄,社会经济地位和免疫状态的影响.
高风险群体包括免疫力低下的个体,老年人和拥挤的环境中的人.
改进的生物标志物和预防疗法显示出降低活性结核病风险的潜力.
人工智能集成为更好的TBI管理提供了个性化的治疗计划.
随着COVID-19的流行,TBI的诊断和护理受到负面影响,远程医疗成为潜在的长期解决方案.

结论:

创伤仍然是一个重大的全球健康挑战,需要创新的诊断和治疗策略.
诊断,预防疗法,组合治疗和人工智能集成方面的进步有望改善TBI结果.
解决社会经济因素和获得医疗保健对于TBI控制至关重要.

关键词:

高风险群体高风险群体社会经济因素社会经济因素结核病感染 (TBI) 是一种疾病.易受伤害的人群易受伤害的人群结核病菌菌菌 (M.tb) 是一种

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.